在使用高强度聚焦超声波的网络核心结构恒星聚合物中加速机械孔激活和药物释放.
Jilin Fan1,2, Mingjun Xuan1,2,3, Kuan Zhang1,2,3
1Institute of Technical and Macromolecular Chemistry RWTH Aachen University Worringerweg 2 52074 Aachen Germany.
Small science
|April 11, 2025
概括
高强度聚焦超声波 (HIFU) 激活了类似于较低频率的聚合物机械化学,使药物有效释放. 这一进步对超声药理学应用具有前景.
科学领域:
- 聚合物化学 聚合物化学
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
背景情况:
- 聚合物中的机制体的超声波 (US) 激活是聚合物机械化学的关键.
- 传统的20kHzUS会导致惯性化,限制生物医学用途.
- 网络核心结构恒星聚合物 (NCSPs) 为机械化学应用提供了一个平台.
研究的目的:
- 调查1.5MHz高强度聚焦超声波 (HIFU) 用于激活NCSP中的二硫化物机械孔.
- 为了比较HIFU激活效率与传统的20kHz美国.
- 为了证明HIFU介导的药物释放从NCSPs用于声药学.
主要方法:
- 使用20kHz的US和1.5MHz的HIFU,用二硫化物机械照射NCSP.
- 采用"打开"传感器分子 (迈克尔补充,逆向迪尔斯-阿尔德) 来量化机械孔激活.
- 共同加载抗癌药物多克索鲁比 (Dox) 进入NCSP进行释放研究.
- 进行了体外研究,以评估药物释放动力学.
主要成果:
- 1.5 MHz的HIFU在激活NCSP中的二硫化物机械方面表现出与20kHz的US相当的效率.
- 观察到机械化学聚合物链裂变.
- 从NCSP中有效释放多克索鲁比辛 (Dox) 是使用1.5MHz的HIFU实现的.
- 在体外释放药物的研究证实了这种方法的潜力.
结论:
- 1.5 MHz HIFU 是用于聚合物机械化学的20 kHz US的有效替代品.
- 通过HIFU激活的聚合物机械化学显示出对声医药学的重大潜力.
- 这种技术使生物医学领域的药物输送控制应用成为可能.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
Modified-Release Drug Delivery Systems: Classification
315
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
315
Modified-Release Drug Delivery Systems: Rate-Programmed I
172
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
172
Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160


